238 related articles for article (PubMed ID: 34109887)
1. Preparation and characterization of paclitaxel palmitate albumin nanoparticles with high loading efficacy: an in vitro and in vivo anti-tumor study in mouse models.
Chen H; Huang S; Wang H; Chen X; Zhang H; Xu Y; Fan W; Pan Y; Wen Q; Lin Z; Wang X; Gu Y; Ding B; Chen J; Wu X
Drug Deliv; 2021 Dec; 28(1):1067-1079. PubMed ID: 34109887
[TBL] [Abstract][Full Text] [Related]
2. Improved anticancer effects of albumin-bound paclitaxel nanoparticle via augmentation of EPR effect and albumin-protein interactions using S-nitrosated human serum albumin dimer.
Kinoshita R; Ishima Y; Chuang VTG; Nakamura H; Fang J; Watanabe H; Shimizu T; Okuhira K; Ishida T; Maeda H; Otagiri M; Maruyama T
Biomaterials; 2017 Sep; 140():162-169. PubMed ID: 28651144
[TBL] [Abstract][Full Text] [Related]
3. Reduction-Responsive and Multidrug Deliverable Albumin Nanoparticles: An Antitumor Drug to Abraxane against Human Pancreatic Tumor-Bearing Mice.
Hirakawa N; Ishima Y; Kinoshita R; Nakano R; Chuang VTG; Ando H; Shimizu T; Okuhira K; Maruyama T; Otagiri M; Ishida T
ACS Appl Bio Mater; 2021 May; 4(5):4302-4309. PubMed ID: 35006842
[TBL] [Abstract][Full Text] [Related]
4. Development of biocompatible and VEGF-targeted paclitaxel nanodrugs on albumin and graphene oxide dual-carrier for photothermal-triggered drug delivery in vitro and in vivo.
Deng W; Qiu J; Wang S; Yuan Z; Jia Y; Tan H; Lu J; Zheng R
Int J Nanomedicine; 2018; 13():439-453. PubMed ID: 29403275
[TBL] [Abstract][Full Text] [Related]
5. Enhanced performance of macrophage-encapsulated nanoparticle albumin-bound-paclitaxel in hypo-perfused cancer lesions.
Leonard F; Curtis LT; Yesantharao P; Tanei T; Alexander JF; Wu M; Lowengrub J; Liu X; Ferrari M; Yokoi K; Frieboes HB; Godin B
Nanoscale; 2016 Jul; 8(25):12544-52. PubMed ID: 26818212
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-Loaded TPGS-b-PCL Nanoparticles: In Vitro Cytotoxicity and Cellular Uptake in MCF-7 and MDA-MB-231 Cells versus mPEG-b-PCL Nanoparticles and Abraxane®.
Bernabeu E; Gonzalez L; Legaspi MJ; Moretton MA; Chiappetta DA
J Nanosci Nanotechnol; 2016 Jan; 16(1):160-70. PubMed ID: 27398441
[TBL] [Abstract][Full Text] [Related]
7. An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy.
Zhao Y; Cai C; Liu M; Zhao Y; Pei W; Chu X; Zhang H; Wang Z; Han J
Colloids Surf B Biointerfaces; 2019 Nov; 183():110394. PubMed ID: 31398618
[TBL] [Abstract][Full Text] [Related]
8. Facile one-pot formulation of TRAIL-embedded paclitaxel-bound albumin nanoparticles for the treatment of pancreatic cancer.
Min SY; Byeon HJ; Lee C; Seo J; Lee ES; Shin BS; Choi HG; Lee KC; Youn YS
Int J Pharm; 2015 Oct; 494(1):506-15. PubMed ID: 26315118
[TBL] [Abstract][Full Text] [Related]
9. Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation.
Zhao Y; Cai C; Liu M; Zhao Y; Wu Y; Fan Z; Ding Z; Zhang H; Wang Z; Han J
Int J Biol Macromol; 2020 Jun; 153():873-882. PubMed ID: 32169451
[TBL] [Abstract][Full Text] [Related]
10. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
Battogtokh G; Kang JH; Ko YT
Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
[TBL] [Abstract][Full Text] [Related]
11. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
[TBL] [Abstract][Full Text] [Related]
12. Layer-by-layer assembly of hierarchical nanoarchitectures to enhance the systemic performance of nanoparticle albumin-bound paclitaxel.
Ruttala HB; Ramasamy T; Shin BS; Choi HG; Yong CS; Kim JO
Int J Pharm; 2017 Mar; 519(1-2):11-21. PubMed ID: 28069389
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy in HER2-negative breast cancer.
Yang M; Qu H; Liu A; Liu J; Sun P; Li H
J Cancer Res Ther; 2019; 15(7):1561-1566. PubMed ID: 31939438
[TBL] [Abstract][Full Text] [Related]
14. A novel preparative method for nanoparticle albumin-bound paclitaxel with high drug loading and its evaluation both in vitro and in vivo.
Gao Y; Nai J; Yang Z; Zhang J; Ma S; Zhao Y; Li H; Li J; Yang Y; Yang M; Wang Y; Gong W; Yu F; Gao C; Li Z; Mei X
PLoS One; 2021; 16(4):e0250670. PubMed ID: 33909691
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy.
Pandya AD; Jäger E; Bagheri Fam S; Höcherl A; Jäger A; Sincari V; Nyström B; Štěpánek P; Skotland T; Sandvig K; Hrubý M; Mælandsmo GM
Int J Nanomedicine; 2019; 14():6269-6285. PubMed ID: 31496685
[TBL] [Abstract][Full Text] [Related]
16. Antitumor Activity of 1,18-Octadecanedioic Acid-Paclitaxel Complexed with Human Serum Albumin.
Callmann CE; LeGuyader CLM; Burton ST; Thompson MP; Hennis R; Barback C; Henriksen NM; Chan WC; Jaremko MJ; Yang J; Garcia A; Burkart MD; Gilson MK; Momper JD; Bertin PA; Gianneschi NC
J Am Chem Soc; 2019 Jul; 141(30):11765-11769. PubMed ID: 31317744
[TBL] [Abstract][Full Text] [Related]
17. Redirecting Transport of Nanoparticle Albumin-Bound Paclitaxel to Macrophages Enhances Therapeutic Efficacy against Liver Metastases.
Tanei T; Leonard F; Liu X; Alexander JF; Saito Y; Ferrari M; Godin B; Yokoi K
Cancer Res; 2016 Jan; 76(2):429-39. PubMed ID: 26744528
[TBL] [Abstract][Full Text] [Related]
18. A toxic organic solvent-free technology for the preparation of PEGylated paclitaxel nanosuspension based on human serum albumin for effective cancer therapy.
Yin T; Dong L; Cui B; Wang L; Yin L; Zhou J; Huo M
Int J Nanomedicine; 2015; 10():7397-412. PubMed ID: 26715846
[TBL] [Abstract][Full Text] [Related]
19. Preparation and Characterization of Albumin Nanoparticles of Paclitaxel-Triphenylphosphonium Conjugates: New Approach to Subcellular Targeting.
Hosseinifar N; Goodarzi N; Sharif AAM; Amini M; Esfandyari-Manesh M; Dinarvand R
Drug Res (Stuttg); 2020 Feb; 70(2-03):71-79. PubMed ID: 31986546
[TBL] [Abstract][Full Text] [Related]
20. Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy.
Ruttala HB; Ko YT
Colloids Surf B Biointerfaces; 2015 Apr; 128():419-426. PubMed ID: 25797481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
